226 related articles for article (PubMed ID: 16571899)
1. Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy.
Albertini V; Jain A; Vignati S; Napoli S; Rinaldi A; Kwee I; Nur-e-Alam M; Bergant J; Bertoni F; Carbone GM; Rohr J; Catapano CV
Nucleic Acids Res; 2006; 34(6):1721-34. PubMed ID: 16571899
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts.
Previdi S; Malek A; Albertini V; Riva C; Capella C; Broggini M; Carbone GM; Rohr J; Catapano CV
Gynecol Oncol; 2010 Aug; 118(2):182-8. PubMed ID: 20452660
[TBL] [Abstract][Full Text] [Related]
3. Mithramycin SK, a novel antitumor drug with improved therapeutic index, mithramycin SA, and demycarosyl-mithramycin SK: three new products generated in the mithramycin producer Streptomyces argillaceus through combinatorial biosynthesis.
Remsing LL; González AM; Nur-e-Alam M; Fernández-Lozano MJ; Braña AF; Rix U; Oliveira MA; Méndez C; Salas JA; Rohr J
J Am Chem Soc; 2003 May; 125(19):5745-53. PubMed ID: 12733914
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the activity of Sp transcription factors by mithramycin analogues as a new strategy for treatment of metastatic prostate cancer.
Malek A; Núñez LE; Magistri M; Brambilla L; Jovic S; Carbone GM; Morís F; Catapano CV
PLoS One; 2012; 7(4):e35130. PubMed ID: 22545098
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of c-src transcription by mithramycin: structure-activity relationships of biosynthetically produced mithramycin analogues using the c-src promoter as target.
Remsing LL; Bahadori HR; Carbone GM; McGuffie EM; Catapano CV; Rohr J
Biochemistry; 2003 Jul; 42(27):8313-24. PubMed ID: 12846580
[TBL] [Abstract][Full Text] [Related]
6. Mithramycin analogues generated by combinatorial biosynthesis show improved bioactivity.
Baig I; Perez M; Braña AF; Gomathinayagam R; Damodaran C; Salas JA; Méndez C; Rohr J
J Nat Prod; 2008 Feb; 71(2):199-207. PubMed ID: 18197601
[TBL] [Abstract][Full Text] [Related]
7. The antitumor antibiotic mithramycin: new advanced approaches in modification and production.
Kormanec J; Novakova R; Csolleiova D; Feckova L; Rezuchova B; Sevcikova B; Homerova D
Appl Microbiol Biotechnol; 2020 Sep; 104(18):7701-7721. PubMed ID: 32686008
[TBL] [Abstract][Full Text] [Related]
8. The aureolic acid family of antitumor compounds: structure, mode of action, biosynthesis, and novel derivatives.
Lombó F; Menéndez N; Salas JA; Méndez C
Appl Microbiol Biotechnol; 2006 Nov; 73(1):1-14. PubMed ID: 17013601
[TBL] [Abstract][Full Text] [Related]
9. The activity of a novel mithramycin analog is related to its binding to DNA, cellular accumulation, and inhibition of Sp1-driven gene transcription.
Fernández-Guizán A; Mansilla S; Barceló F; Vizcaíno C; Núñez LE; Morís F; González S; Portugal J
Chem Biol Interact; 2014 Aug; 219():123-32. PubMed ID: 24907531
[TBL] [Abstract][Full Text] [Related]
10. Ketopremithramycins and ketomithramycins, four new aureolic acid-type compounds obtained upon inactivation of two genes involved in the biosynthesis of the deoxysugar moieties of the antitumor drug mithramycin by Streptomyces argillaceus, reveal novel insights into post-PKS tailoring steps of the mithramycin biosynthetic pathway.
Remsing LL; Garcia-Bernardo J; Gonzalez A; Künzel E; Rix U; Braña AF; Bearden DW; Méndez C; Salas JA; Rohr J
J Am Chem Soc; 2002 Feb; 124(8):1606-14. PubMed ID: 11853433
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity.
Scott D; Rohr J; Bae Y
Int J Nanomedicine; 2011; 6():2757-67. PubMed ID: 22114504
[TBL] [Abstract][Full Text] [Related]
12. Dimerization and DNA recognition rules of mithramycin and its analogues.
Weidenbach S; Hou C; Chen JM; Tsodikov OV; Rohr J
J Inorg Biochem; 2016 Mar; 156():40-7. PubMed ID: 26760230
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide modulation of gene transcription in ovarian carcinoma cells by a new mithramycin analogue.
Vizcaíno C; Núñez LE; Morís F; Portugal J
PLoS One; 2014; 9(8):e104687. PubMed ID: 25110883
[TBL] [Abstract][Full Text] [Related]
14. A novel mithramycin analogue with high antitumor activity and less toxicity generated by combinatorial biosynthesis.
Núñez LE; Nybo SE; González-Sabín J; Pérez M; Menéndez N; Braña AF; Shaaban KA; He M; Morís F; Salas JA; Rohr J; Méndez C
J Med Chem; 2012 Jun; 55(12):5813-25. PubMed ID: 22578073
[TBL] [Abstract][Full Text] [Related]
15. Engineering precursor metabolite pools for increasing production of antitumor mithramycins in Streptomyces argillaceus.
Zabala D; Braña AF; Flórez AB; Salas JA; Méndez C
Metab Eng; 2013 Nov; 20():187-97. PubMed ID: 24148183
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of mithramycin biosynthesis in Streptomyces argillaceus: dual role as activator and repressor of the PadR-like regulator MtrY.
Flórez AB; Álvarez S; Zabala D; Braña AF; Salas JA; Méndez C
Microbiology (Reading); 2015 Feb; 161(Pt 2):272-284. PubMed ID: 25416691
[TBL] [Abstract][Full Text] [Related]
17. Oxidative cleavage of premithramycin B is one of the last steps in the biosynthesis of the antitumor drug mithramycin.
Prado L; Fernández E; Weissbach U; Blanco G; Quirós LM; Braña AF; Méndez C; Rohr J; Salas JA
Chem Biol; 1999 Jan; 6(1):19-30. PubMed ID: 9889148
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Streptomyces argillaceus genes encoding a polyketide synthase involved in the biosynthesis of the antitumor mithramycin.
Lombó F; Blanco G; Fernández E; Méndez C; Salas JA
Gene; 1996 Jun; 172(1):87-91. PubMed ID: 8654997
[TBL] [Abstract][Full Text] [Related]
19. Sequence-selective DNA binding drugs mithramycin A and chromomycin A3 are potent inhibitors of neuronal apoptosis induced by oxidative stress and DNA damage in cortical neurons.
Chatterjee S; Zaman K; Ryu H; Conforto A; Ratan RR
Ann Neurol; 2001 Mar; 49(3):345-54. PubMed ID: 11261509
[TBL] [Abstract][Full Text] [Related]
20. Insertional inactivation of mtrX and mtrY genes from the mithramycin gene cluster affects production and growth of the producer organism Streptomyces argillaceus.
Garcia-Bernardo J; Braña AF; Méndez C; Salas JA
FEMS Microbiol Lett; 2000 May; 186(1):61-5. PubMed ID: 10779713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
